Vonjo 100 MG capsule 120S
Ended Awarded
- Contract number
- SPE2DB26FQ80W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,749
Award facts
- Contract value 100% obligated
- $15,748.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,748.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp for supply of Vonjo (ruxolitinib) 100 mg capsules in quantities of 120 units. The award was made on October 30, 2025, with an ultimate completion date of November 21, 2025. No set-aside designation was used in this competitive award. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. The company maintains an extensive portfolio of pharmaceutical deliveries covering diabetes medications, neurological treatments, pain management pharmaceuticals, antibiotics, vaccines, and specialized medical supplies. This specific delivery order for Vonjo—a medication indicated for myelofibrosis and polycythemia vera—reflects the company's capability to supply specialized pharmaceutical products to support Defense Health Agency requirements and other federal healthcare systems through open competition and firm fixed-price arrangements.
Quick answers
Who was awarded contract SPE2DB26FQ80W?
SPE2DB26FQ80W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DB26FQ80W worth?
The government has obligated $15,749 on SPE2DB26FQ80W.
Is contract SPE2DB26FQ80W an order under another contract?
Yes. SPE2DB26FQ80W is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB26FQ80W competed?
The extent of competition for SPE2DB26FQ80W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award